UCL Technology Fund’s first investment to IPO has seen MeiraGTx Holdings, a clinical stage gene therapy company, raise USD75 million of gross proceeds from a public offering on 12 June.
By Fiona Le Poidevin, TISE – There were 705 new listings on The International Stock Exchange (TISE) during 2017, which was an increase of 40 per cent on the previous year. In the first quarter of 2018, there was a 16.5 per cent rise year on year in new business, which took the total number of listed securities on the Exchange to 2,606 at the end of March 2018. These listings comprise a mix of equity and debt being issued by operating companies and nearly 400 securities issued by investment vehicles, including open and closed-ended funds and more than a quarter of all HMRC approved Real Estate Investment Trusts (REITs).
The London office of international law firm Winston & Strawn represented Mind Gym PLC on its GBP145 million listing on the AIM market of the London Stock Exchange.
Singapore Exchange (SGX) today welcomed the listing of the Astrea IV private equity (PE) Class A-1 bonds issued by Azalea Group, an indirect wholly owned subsidiary of Temasek Holdings. The issuance marks the first such structure in Singapore for retail investors to subscribe to PE bonds.
Noerr has advised Mutares AG as Corporate Counsel with regard to the stock exchange and capital markets law on the planned IPO of its subsidiary STS Group AG and is also supporting the preparatory corporate actions at the level of STS Group AG.
A Q&A with Greg Wojciechowski, President and CEO at Bermuda Stock Exchange (BSX)…
Aquis Technologies, the financial and regulatory technologies services arm of Aquis Exchange, has been appointed to supply trading technology to Estates and Infrastructure Exchange (EIE).
Flexion Mobile Limited, a London-based company that provides its game distribution platform to developers, has raised USD10 million to continue its global expansion and will now apply for listing on Nasdaq First North in Stockholm during 2018.
Gide has advised Erytech Pharma, a company listed on Euronext Paris, on its initial public offering on the Nasdaq Global Select Market, through a reserved capital increase to American and European specialist investors for a total aggregate amount of USD144 million, after full exercise of the over-allotment option.
Apellis Pharmaceuticals, a portfolio company of early-stage venture capital fund Epidarex Capital, has completed its initial public offering (IPO).